Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Atezolizumab Market Growth 2022-2028

  • LP 4768457
  • 76 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Atezolizumab will have significant change from previous year. According to our (LP Information) latest study, the global Atezolizumab market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Atezolizumab market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Atezolizumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Atezolizumab market, reaching US$ million by the year 2028. As for the Europe Atezolizumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Atezolizumab players cover Genentech (Roche), , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Atezolizumab market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Use: Single Drug

Use: Chemotherapy Combination

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Bladder Cancer

Lung Cancer

Advanced Triple-negative Breast Cancer

Head and Neck Cancer

Urothelial Carcinoma

Renal Cell Carcinoma

Hepatocellular Carcinoma (HCC)

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Genentech (Roche)

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Atezolizumab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Atezolizumab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Atezolizumab by Country/Region, 2017, 2022 & 2028

2.2 Atezolizumab Segment by Type

2.2.1 Use: Single Drug

2.2.2 Use: Chemotherapy Combination

2.3 Atezolizumab Sales by Type

2.3.1 Global Atezolizumab Sales Market Share by Type (2017-2022)

2.3.2 Global Atezolizumab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Atezolizumab Sale Price by Type (2017-2022)

2.4 Atezolizumab Segment by Application

2.4.1 Bladder Cancer

2.4.2 Lung Cancer

2.4.3 Advanced Triple-negative Breast Cancer

2.4.4 Head and Neck Cancer

2.4.5 Urothelial Carcinoma

2.4.6 Renal Cell Carcinoma

2.4.7 Hepatocellular Carcinoma (HCC)

2.4.8 Other

2.5 Atezolizumab Sales by Application

2.5.1 Global Atezolizumab Sale Market Share by Application (2017-2022)

2.5.2 Global Atezolizumab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Atezolizumab Sale Price by Application (2017-2022)

3 Global Atezolizumab by Company

3.1 Global Atezolizumab Breakdown Data by Company

3.1.1 Global Atezolizumab Annual Sales by Company (2020-2022)

3.1.2 Global Atezolizumab Sales Market Share by Company (2020-2022)

3.2 Global Atezolizumab Annual Revenue by Company (2020-2022)

3.2.1 Global Atezolizumab Revenue by Company (2020-2022)

3.2.2 Global Atezolizumab Revenue Market Share by Company (2020-2022)

3.3 Global Atezolizumab Sale Price by Company

3.4 Key Manufacturers Atezolizumab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Atezolizumab Product Location Distribution

3.4.2 Players Atezolizumab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Atezolizumab by Geographic Region

4.1 World Historic Atezolizumab Market Size by Geographic Region (2017-2022)

4.1.1 Global Atezolizumab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Atezolizumab Annual Revenue by Geographic Region

4.2 World Historic Atezolizumab Market Size by Country/Region (2017-2022)

4.2.1 Global Atezolizumab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Atezolizumab Annual Revenue by Country/Region

4.3 Americas Atezolizumab Sales Growth

4.4 APAC Atezolizumab Sales Growth

4.5 Europe Atezolizumab Sales Growth

4.6 Middle East & Africa Atezolizumab Sales Growth

5 Americas

5.1 Americas Atezolizumab Sales by Country

5.1.1 Americas Atezolizumab Sales by Country (2017-2022)

5.1.2 Americas Atezolizumab Revenue by Country (2017-2022)

5.2 Americas Atezolizumab Sales by Type

5.3 Americas Atezolizumab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Atezolizumab Sales by Region

6.1.1 APAC Atezolizumab Sales by Region (2017-2022)

6.1.2 APAC Atezolizumab Revenue by Region (2017-2022)

6.2 APAC Atezolizumab Sales by Type

6.3 APAC Atezolizumab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Atezolizumab by Country

7.1.1 Europe Atezolizumab Sales by Country (2017-2022)

7.1.2 Europe Atezolizumab Revenue by Country (2017-2022)

7.2 Europe Atezolizumab Sales by Type

7.3 Europe Atezolizumab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Atezolizumab by Country

8.1.1 Middle East & Africa Atezolizumab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Atezolizumab Revenue by Country (2017-2022)

8.2 Middle East & Africa Atezolizumab Sales by Type

8.3 Middle East & Africa Atezolizumab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Atezolizumab

10.3 Manufacturing Process Analysis of Atezolizumab

10.4 Industry Chain Structure of Atezolizumab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Atezolizumab Distributors

11.3 Atezolizumab Customer

12 World Forecast Review for Atezolizumab by Geographic Region

12.1 Global Atezolizumab Market Size Forecast by Region

12.1.1 Global Atezolizumab Forecast by Region (2023-2028)

12.1.2 Global Atezolizumab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Atezolizumab Forecast by Type

12.7 Global Atezolizumab Forecast by Application

13 Key Players Analysis

13.1 Genentech (Roche)

13.1.1 Genentech (Roche) Company Information

13.1.2 Genentech (Roche) Atezolizumab Product Offered

13.1.3 Genentech (Roche) Atezolizumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Genentech (Roche) Main Business Overview

13.1.5 Genentech (Roche) Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Atezolizumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Atezolizumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Use: Single Drug

Table 4. Major Players of Use: Chemotherapy Combination

Table 5. Global Atezolizumab Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Atezolizumab Sales Market Share by Type (2017-2022)

Table 7. Global Atezolizumab Revenue by Type (2017-2022) & ($ million)

Table 8. Global Atezolizumab Revenue Market Share by Type (2017-2022)

Table 9. Global Atezolizumab Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Atezolizumab Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Atezolizumab Sales Market Share by Application (2017-2022)

Table 12. Global Atezolizumab Revenue by Application (2017-2022)

Table 13. Global Atezolizumab Revenue Market Share by Application (2017-2022)

Table 14. Global Atezolizumab Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Atezolizumab Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Atezolizumab Sales Market Share by Company (2020-2022)

Table 17. Global Atezolizumab Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Atezolizumab Revenue Market Share by Company (2020-2022)

Table 19. Global Atezolizumab Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Atezolizumab Producing Area Distribution and Sales Area

Table 21. Players Atezolizumab Products Offered

Table 22. Atezolizumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Atezolizumab Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Atezolizumab Sales Market Share Geographic Region (2017-2022)

Table 27. Global Atezolizumab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Atezolizumab Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Atezolizumab Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Atezolizumab Sales Market Share by Country/Region (2017-2022)

Table 31. Global Atezolizumab Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Atezolizumab Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Atezolizumab Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Atezolizumab Sales Market Share by Country (2017-2022)

Table 35. Americas Atezolizumab Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Atezolizumab Revenue Market Share by Country (2017-2022)

Table 37. Americas Atezolizumab Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Atezolizumab Sales Market Share by Type (2017-2022)

Table 39. Americas Atezolizumab Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Atezolizumab Sales Market Share by Application (2017-2022)

Table 41. APAC Atezolizumab Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Atezolizumab Sales Market Share by Region (2017-2022)

Table 43. APAC Atezolizumab Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Atezolizumab Revenue Market Share by Region (2017-2022)

Table 45. APAC Atezolizumab Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Atezolizumab Sales Market Share by Type (2017-2022)

Table 47. APAC Atezolizumab Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Atezolizumab Sales Market Share by Application (2017-2022)

Table 49. Europe Atezolizumab Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Atezolizumab Sales Market Share by Country (2017-2022)

Table 51. Europe Atezolizumab Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Atezolizumab Revenue Market Share by Country (2017-2022)

Table 53. Europe Atezolizumab Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Atezolizumab Sales Market Share by Type (2017-2022)

Table 55. Europe Atezolizumab Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Atezolizumab Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Atezolizumab Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Atezolizumab Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Atezolizumab Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Atezolizumab Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Atezolizumab Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Atezolizumab Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Atezolizumab Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Atezolizumab Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Atezolizumab

Table 66. Key Market Challenges & Risks of Atezolizumab

Table 67. Key Industry Trends of Atezolizumab

Table 68. Atezolizumab Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Atezolizumab Distributors List

Table 71. Atezolizumab Customer List

Table 72. Global Atezolizumab Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Atezolizumab Sales Market Forecast by Region

Table 74. Global Atezolizumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Atezolizumab Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Atezolizumab Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Atezolizumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Atezolizumab Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Atezolizumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Atezolizumab Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Atezolizumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Atezolizumab Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Atezolizumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Atezolizumab Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Atezolizumab Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Atezolizumab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Atezolizumab Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Atezolizumab Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Atezolizumab Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Atezolizumab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Atezolizumab Revenue Market Share Forecast by Application (2023-2028)

Table 92. Genentech (Roche) Basic Information, Atezolizumab Manufacturing Base, Sales Area and Its Competitors

Table 93. Genentech (Roche) Atezolizumab Product Offered

Table 94. Genentech (Roche) Atezolizumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Genentech (Roche) Main Business

Table 96. Genentech (Roche) Latest Developments

List of Figures

Figure 1. Picture of Atezolizumab

Figure 2. Atezolizumab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Atezolizumab Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Atezolizumab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Atezolizumab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Use: Single Drug

Figure 10. Product Picture of Use: Chemotherapy Combination

Figure 11. Global Atezolizumab Sales Market Share by Type in 2021

Figure 12. Global Atezolizumab Revenue Market Share by Type (2017-2022)

Figure 13. Atezolizumab Consumed in Bladder Cancer

Figure 14. Global Atezolizumab Market: Bladder Cancer (2017-2022) & (K Pcs)

Figure 15. Atezolizumab Consumed in Lung Cancer

Figure 16. Global Atezolizumab Market: Lung Cancer (2017-2022) & (K Pcs)

Figure 17. Atezolizumab Consumed in Advanced Triple-negative Breast Cancer

Figure 18. Global Atezolizumab Market: Advanced Triple-negative Breast Cancer (2017-2022) & (K Pcs)

Figure 19. Atezolizumab Consumed in Head and Neck Cancer

Figure 20. Global Atezolizumab Market: Head and Neck Cancer (2017-2022) & (K Pcs)

Figure 21. Atezolizumab Consumed in Urothelial Carcinoma

Figure 22. Global Atezolizumab Market: Urothelial Carcinoma (2017-2022) & (K Pcs)

Figure 23. Atezolizumab Consumed in Renal Cell Carcinoma

Figure 24. Global Atezolizumab Market: Renal Cell Carcinoma (2017-2022) & (K Pcs)

Figure 25. Atezolizumab Consumed in Hepatocellular Carcinoma (HCC)

Figure 26. Global Atezolizumab Market: Hepatocellular Carcinoma (HCC) (2017-2022) & (K Pcs)

Figure 27. Atezolizumab Consumed in Other

Figure 28. Global Atezolizumab Market: Other (2017-2022) & (K Pcs)

Figure 29. Global Atezolizumab Sales Market Share by Application (2017-2022)

Figure 30. Global Atezolizumab Revenue Market Share by Application in 2021

Figure 31. Atezolizumab Revenue Market by Company in 2021 ($ Million)

Figure 32. Global Atezolizumab Revenue Market Share by Company in 2021

Figure 33. Global Atezolizumab Sales Market Share by Geographic Region (2017-2022)

Figure 34. Global Atezolizumab Revenue Market Share by Geographic Region in 2021

Figure 35. Global Atezolizumab Sales Market Share by Region (2017-2022)

Figure 36. Global Atezolizumab Revenue Market Share by Country/Region in 2021

Figure 37. Americas Atezolizumab Sales 2017-2022 (K Pcs)

Figure 38. Americas Atezolizumab Revenue 2017-2022 ($ Millions)

Figure 39. APAC Atezolizumab Sales 2017-2022 (K Pcs)

Figure 40. APAC Atezolizumab Revenue 2017-2022 ($ Millions)

Figure 41. Europe Atezolizumab Sales 2017-2022 (K Pcs)

Figure 42. Europe Atezolizumab Revenue 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Atezolizumab Sales 2017-2022 (K Pcs)

Figure 44. Middle East & Africa Atezolizumab Revenue 2017-2022 ($ Millions)

Figure 45. Americas Atezolizumab Sales Market Share by Country in 2021

Figure 46. Americas Atezolizumab Revenue Market Share by Country in 2021

Figure 47. United States Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 48. Canada Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 49. Mexico Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 50. Brazil Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 51. APAC Atezolizumab Sales Market Share by Region in 2021

Figure 52. APAC Atezolizumab Revenue Market Share by Regions in 2021

Figure 53. China Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 54. Japan Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 55. South Korea Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 56. Southeast Asia Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 57. India Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 58. Australia Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 59. Europe Atezolizumab Sales Market Share by Country in 2021

Figure 60. Europe Atezolizumab Revenue Market Share by Country in 2021

Figure 61. Germany Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 62. France Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 63. UK Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 64. Italy Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 65. Russia Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 66. Middle East & Africa Atezolizumab Sales Market Share by Country in 2021

Figure 67. Middle East & Africa Atezolizumab Revenue Market Share by Country in 2021

Figure 68. Egypt Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 69. South Africa Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 70. Israel Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 71. Turkey Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 72. GCC Country Atezolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 73. Manufacturing Cost Structure Analysis of Atezolizumab in 2021

Figure 74. Manufacturing Process Analysis of Atezolizumab

Figure 75. Industry Chain Structure of Atezolizumab

Figure 76. Channels of Distribution

Figure 77. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390